☆ 4.6 Letter

A Phase II, Open-Label Evaluation of Cysteamine Tolerability in Patients With Huntington's Disease

MOVEMENT DISORDERS (2015)

Get Full Text
Add to Collection

Journal

MOVEMENT DISORDERS
Volume 30, Issue 2, Pages 288-289

Publisher

WILEY
DOI: 10.1002/mds.26101

Keywords

Huntington's disease; cysteamine; tolerability

Categories

Clinical Neurology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.